European Pharmaceutical Group

Connecting European healthcare resources with China's future

Shuaizhijia Group focuses on pharmaceutical partnerships, commercialization and life-health services for enterprise clients, investors and consumers.

European pharmaceutical laboratory and office corridor

2018

Founded

12+

Countries covered

680+

Employees

40+

Product lines

Shuaizhijia Group

Business Areas

Core capabilities from international cooperation to local commercialization.

Pharmaceutical supply chain and lab operations

Operating Model

Disciplined cross-border execution

Shuaizhijia Group

Group Strengths

We combine European quality systems, pharmaceutical industry resources and China market execution to help partners enter and serve target markets with confidence.

Compliance first

Every project is managed through clear boundaries, traceable workflows and disciplined execution.

Cross-border coordination

We connect European product, R&D and quality teams with China market and service networks.

Long-term operation

We focus on sustainable partnerships, organizational capability and durable market trust.

Shuaizhijia Group

A Long-Term Method From Review to Operation

We turn international cooperation into clear, reviewable and deliverable steps that make professional judgment operational.

01

Product and partner review

Evaluate medical value, compliance path, supply stability and commercial potential.

02

Market entry planning

Define registration, access, channel, brand communication and regional execution strategy.

03

Local commercialization

Operate and improve through local teams, quality systems and partner networks.

Shuaizhijia Group

Latest News

View all news

Company · 2026-04-18

Shuaizhijia Group upgrades European partnership platform

The platform will use the Beijing Changping Vanke Sky City office hub to improve coordination across product partnerships, regulatory affairs and commercialization.

Industry · 2026-03-29

Cross-border pharma supply chains enter a new quality stage

Compliance, traceability and reliable delivery are becoming core partner selection criteria.

Media · 2026-02-14

Media: How European-backed firms serve China's healthcare market

The leadership team discussed the Beijing collaboration hub, global resources, local teams and long-term commitment.